Vivani Medical (VANI) Profit After Tax (2014 - 2026)
Vivani Medical (VANI) posted quarterly Profit After Tax of -$6.8 million for Q1 2026, down 7.58% year-over-year from -$7.3 million in Q1 2025, and down 1.94% quarter-over-quarter from -$6.7 million in Q4 2025.
Vivani Medical (VANI) Profit After Tax (2014 - 2026) Analysis & Trends
Vivani Medical's Profit After Tax history runs 13 years deep, the most recent figure standing at -$6.8 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 7.58% year-over-year to -$6.8 million; the TTM figure through Mar 2026 stood at -$27.1 million (down 14.13% YoY), while the FY2025 annual figure was -$26.6 million, down 13.37% from the prior year.
- Profit After Tax for Q1 2026 stood at -$6.8 million, down from -$6.7 million in the prior quarter.
- The five-year high for Profit After Tax was $1.4 million in Q3 2022, with the low at -$7.3 million in Q4 2022.
- The 5-year median for Profit After Tax is -$6.3 million (2025), against an average of -$5.7 million.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax soared 140.76% in 2022, then sank 577.93% in 2023.
- Vivani Medical's Profit After Tax stood at -$7.3 million in 2022, then gained by 17.27% to -$6.0 million in 2023, then retreated by 0.4% to -$6.0 million in 2024, then fell by 9.93% to -$6.7 million in 2025, then declined by 1.94% to -$6.8 million in 2026.
- Business Quant data shows VANI's Profit After Tax at -$6.8 million in Q1 2026, -$6.7 million in Q4 2025, and -$6.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | -6.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.37 Mn |
| Mar 31, 2026 | -6.78 Mn |
| Dec 31, 2025 | -6.65 Mn |
| Sep 30, 2025 | -6.53 Mn |
| Jun 30, 2025 | -7.14 Mn |
| Mar 31, 2025 | -6.30 Mn |
| Dec 31, 2024 | -6.05 Mn |
| Sep 30, 2024 | -6.04 Mn |
| Jun 30, 2024 | -5.36 Mn |
| Mar 31, 2024 | -6.04 Mn |
| Dec 31, 2023 | -6.03 Mn |
| Sep 30, 2023 | -6.80 Mn |
| Jun 30, 2023 | -6.53 Mn |
| Mar 31, 2023 | -6.32 Mn |
| Dec 31, 2022 | -7.28 Mn |
| Sep 30, 2022 | 1.42 Mn |
| Jun 30, 2022 | -4.10 Mn |
| Mar 31, 2022 | -3.92 Mn |
| Dec 31, 2021 | -1.28 Mn |
| Sep 30, 2021 | -3.49 Mn |